Biogen
BIIB
BIIB
930 hedge funds and large institutions have $29.7B invested in Biogen in 2024 Q2 according to their latest regulatory filings, with 100 funds opening new positions, 317 increasing their positions, 334 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
930
Holders Change
-11
Holders Change %
-1.17%
% of All Funds
13.53%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.16%
New
100
Increased
317
Reduced
334
Closed
95
Calls
$316M
Puts
$353M
Net Calls
-$36.7M
Net Calls Change
-$35.1M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$336M |
| 2 |
Norges Bank
Oslo,
Norway
|
$482M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$1.32B |
| 4 |
Goldman Sachs
New York
|
$329M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$466M |
